| Allied Chemi
Deliver to United Kingdom
0

HPLC column NUCLEODUR ® Phenyl-Hexyl, 1.8 µm, 100 mm, 3 mm

£ 788.54*

*Prices plus VAT plus shipping costs

£ 946.25*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® Phenyl-Hexyl, 1.8 µm, 100 mm, 3 mm

Order number: 34LE.1

Part number: AC100008524

In Stock

Price Breakdown

1

6

24

Engineered for consistent performance, the Hplc Column Nucleodur ® Phenyl-Hexyl, 1.8 μm, 100 mm, 3 mm is designed for use in liquid chromatography (LC, HPLC). This UHPLC column features a Phenyl-Hexyl phase, which offers an alternative selectivity compared to traditional C18 modifications due to its hydrophobic and π-π interaction capabilities. With a pore size of 110 Å and a specific surface area of 340 m²/g, it provides excellent separation efficiency. Its endcapped nature ensures low bleeding characteristics, making it ideal for LC/MS applications. Recommended for antibiotics, aromatic and unsaturated compounds, pharmaceutical products, steroids, and especially polar compounds, this column delivers reliable results under temperatures up to 6

  • Category: Separation columns for HPLC
  • USP listing: L11
  • Surface chemistry: Phenylhexyl modification
  • Endcapped: yes
  • Eluent in column: Acetonitrile - Water
  • Pressure stability: 900 bar
  • Phase: Phenyl-Hexyl
  • Interactions / retention mechanism: π-π and hydrophobic
  • Pore size: 110 Å
  • Recommended application(s): Antibiotics Aromatic and unsaturated compounds Suitable for LC-MS Pharmaceutical products Especially for polar compounds Steroids
  • L x Ø internal (column): 100 x 3 mm
  • Specific surface according to BET: 340 m²/g
  • Temperature stability: 60 ° C
  • Column shape: Analytical separation column
  • pH stability: 1,0-10,0
  • Separation principle: Reversed phase (RP)
  • Column volume: 0.7 ml
  • Particle size: 1.8 µm
  • Column type: UHPLC column
  • Particle type: Fully porous particles (FPP)
  • Pore volume: 0.9 ml/g
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.